ASIC1a regulates miR‐350/SPRY2 by N 6 ‐methyladenosine to promote liver fibrosis-Reference-Cited by-同舟云学术

ASIC1a regulates miR‐350/SPRY2 by N 6 ‐methyladenosine to promote liver fibrosis

Published:2020-09-19 Issue:11 Volume:34 Page:14371-14388
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zhu Yueqin¹,Pan Xuesheng¹,Du Na¹,Li Kuayue¹,Hu Yamin¹,Wang Lili¹,Zhang Jin¹,Liu Yanyi¹,Zuo Longquan²,Meng Xiaoming¹,Hu Chengmu¹,Wu xian¹,Jin Juan³,Wu Wenyong⁴,Chen Xiangtao¹,Wu Fanrong¹,Huang Yan¹

Affiliation:

1. Anhui Provincial laboratory of inflammatory and immunity disease Anhui Institute of Innovative Drugs School of Pharmacy Anhui Medical University, 230032, China Hefei230032China

2. Department of Pharmacy Hospital of Armed Police of Anhui Province Hefei230041China

3. Department of Pharmacology, School of Basic Medical Sciences Anhui Medical University Hefei230032China

4. ⁴Department of General Surgery First Affiliated Hospital of Anhui Medical University Hefei230022China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202001337R

Reference68 articles.

1. Liver fibrosis

2. Potential protective effects of a traditional Chinese herb, Litsea coreana Levl., on liver fibrosis in rats